Asia Pacific Academy of Science Pte. Ltd. (APACSCI) specializes in international journal publishing. APACSCI adopts the open access publishing model and provides an important communication bridge for academic groups whose interest fields include engineering, technology, medicine, computer, mathematics, agriculture and forestry, and environment.
Psoriasis is a common, chronic, and inflammatory skin disease. Macrophages account for about 61.3% of the inflammatory cells infiltrating psoriatic lesions. Modulating macrophage polarization, inhibiting their infiltration, and targeting the secretion of inflammatory factors and associated inflammatory pathways by these cells can alleviate psoriasis symptoms and inflammation. Moreover, nanomaterials as novel drug carriers, offer unique advantages such as large surface area, easy modification, high biocompatibility, good biodegradability, enhanced systemic adsorption, etc. Nanomaterials have great potential for efficient drug delivery and release, as well as improving therapeutic efficacy while reducing adverse effects. By systematically addressing the role of macrophages in psoriasis pathogenesis and the potential of nanomaterials in treating psoriasis through modulating macrophages, this review enhances our understanding of the disease mechanism and holds promise for novel therapeutic breakthroughs and advancements in the future treatment of psoriasis.
Vol 30, No 1 (2016) - Article
Ancillary therapy of intranasal T-LysYal® for patients with allergic, non-allergic, and mixed rhinitis Abstract
Vol 30, No 1 (2016) - Article
Hypertonic saline monotherapy in children with perennial allergic rhinitis: a pilot study Abstract
Vol 30, No 1 (2016) - Article
Intranasal T-LysYal® as adjunctive therapy for patients after functional endoscopic sinus surgery Abstract
Vol 30, No 3 (2016) - Article
STANDARDIZATION PROCEDURE FOR THE NASAL NITRIC OXIDE MEASUREMENT METHOD USING NIOX MINO® AND THE TIDAL-BREATHING TECHNIQUE WITH VELUM-CLOSURE Abstract
Vol 30, No 4 (2016) - Article
Nasal irrigation with Nasir® in children: a preliminary experience on nasal cytology Abstract
Vol 35, No 4 (2021) - Article
Management of recurrent cystitis in clinical practice: a nationwide survey Details
Vol 33, No 2 (2019) - Article
Sinerga may prevent recurrent respiratory infections in allergic children Abstract
Vol 33, No 2 (2019) - Article
Broser® (bromelain, escin and selenium), oral nutraceutical, monotherapy in patients with inflammatory otorhinolaryngological disorders Abstract
Vol 33, No 2 (2019) - Article
A polycentric, randomized, double blind, parallel-group, placebo-controlled study on Lertal®, a multicomponent nutraceutical, as add-on treatment in children with allergic rhinoconjunctivitis: phase I during active treatment Abstract
Vol 36, No 2S2 (2022) - Article
Foreword: Supplement on immune manipulation of patients with upper respiratory infections Details
Vol 36, No 2S2 (2022) - Article
Bifidobacterium animalis subsp. lactis BB-12 and cow milk-related symptoms in infants: a reallife experience Abstract
Vol 36, No 2S2 (2022) - Article
Bifidobacterium animalis subsp. lactis BB-12 and infant regurgitation: a real-life experience Abstract
Vol 36, No 2S2 (2022) - Article
Probiotics, zinc, inulin, and vitamin D as an ancillary treatment for patients with acute rhinosinusitis Abstract
Vol 36, No 2S2 (2022) - Article
Probiotics, zinc, inulin, and vitamin D as an ancillary treatment for patients with acute pharyngotonsillitis Abstract
Vol 36, No 2S2 (2022) - Article
Probiotics, zinc, inulin, and vitamin D as an ancillary treatment for patients with acute otitis Abstract
Vol 36, No 2S2 (2022) - Article
Immune manipulation in managing patients with upper airways infections: a new strategy Details
Vol 36, No 2S2 (2022) - Article
A multicomponent food supplement with bromelain, escin, and selenium in patients with urological medical disorders Abstract
Vol 36, No 2S2 (2022) - Article
A multicomponent food supplement with bromelain, escin, and selenium in patients with urological post-surgical complaints Abstract
Vol 36, No 2S2 (2022) - Article
LumiHeal® and Anti-inflammatory Regenerative Medicine (AIMED): a new management strategy for shortening wound healing and effective outcomes, from Repair 1.0 to Wound Regeneration 4.0 Abstract
Vol 35, No 1S2 (2021) - Article
The management of upper airway diseases: an ongoing challenge for the clinician Abstract
Vol 35, No 1S2 (2021) - Article
Glycyrrhizin for topical use and prophylaxis of COVID-19: an interesting pharmacological perspective Abstract
Vol 34, No 6S1 (2020) - Article
Probiotics in the add-on treatment of rhinosinusitis: a clinical experience Abstract
Vol 34, No 6S1 (2020) - Article
Probiotics in the add-on treatment of laryngotracheitis: a clinical experience Abstract
Vol 34, No 6S1 (2020) - Article
Non-pharmacological remedies for upper respiratory diseases in the pandemic COVID-19 era Abstract
Vol 34, No 6S1 (2020) - Article
A probiotic mixture in patients with upper respiratory diseases: the point of view of the otorhinolaringologist Abstract
Vol 25, No 4 (2011) - Article
Immune response to sublingual immunotherapy in children allergic to mites Abstract
Vol 32, No 1S2 (2018) - Article
FOCUS ON GASTROESOPHAGEAL REFLUX (GER) AND LARYNGOPHARYNGEAL REFLUX (LPR): NEW PRAGMATIC INSIGHTS IN CLINICAL PRACTICE Details
In addition to the first issue that has already been published by the original publisher, there will be four more issues released this year, with scheduled publication dates in March, June, September, and December respectively.
Starting from Volume 39 Issue 2 (2025), the ownership of Journal of Biological Regulators and Homeostatic Agents (ISSN: 0393-974X (P); 1724-6083 (O)) will be transferred from Biolife Sas to Asia Pacific Academy of Science Pte. Ltd. As of 21 January 2025, authors should make submissions to the new journal system and follow the author guidelines. Asia Pacific Academy of Science Pte. Ltd. will take over the publication of manuscripts being processed.
